Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells

Kim,Gi  Dae; Oh,Jedo; Park,Hyen-Joo; Bae,Kihwan; Lee,Sang  Kook

doi:10.3892/ijo.2013.1959

Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells

Authors:
- Gi Dae Kim
- Jedo Oh
- Hyen-Joo Park
- Kihwan Bae
- Sang Kook Lee
View Affiliations

Affiliations: Natural Products Research Institute, College of Pharmacy, Seoul National University, Gwanak-gu, Seoul 151-742, Republic of Korea, College of Pharmacy, Chungnam National University, Daejon, Republic of Korea
Published online on: May 24, 2013 https://doi.org/10.3892/ijo.2013.1959
Pages: 600-610

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Magnolol, a neolignan from the traditional medicinal plant Magnolia obovata, has been shown to possess neuroprotective, anti-inflammatory, anticancer and anti-angiogenic activities. However, the precise mechanism of the anti-angiogenic activity of magnolol remains to be elucidated. In the present study, the anti-angiogenic effect of magnolol was evaluated in mouse embryonic stem (mES)/embryoid body (EB)-derived endothelial-like cells. The endothelial-like cells were obtained by differentiation from mES/EB cells. Magnolol (20 µM) significantly suppressed the transcriptional and translational expression of platelet endothelial cell adhesion molecule (PECAM), an endothelial biomarker, in mES/EB-derived endothelial-like cells. To further understand the molecular mechanism of the suppression of PECAM expression, signaling pathways were analyzed in the mES/EB-derived endothelial-like cells. Magnolol induced the generation of reactive oxygen species (ROS) by mitochondria, a process that was associated with the induction of apoptosis as determined by positive Annexin V staining and the activation of cleaved caspase-3. The involvement of ROS generation by magnolol was confirmed by treatment with an antioxidant, N-acetyl-cysteine (NAC). NAC inhibited the magnolol-mediated induction of ROS generation and suppression of PECAM expression. In addition, magnolol suppressed the activation of MAPKs (ERK, JNK and p38) and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells. Taken together, these findings demonstrate for the first time that the anti-angiogenic activity of magnolol may be associated with ROS-mediated apoptosis and the suppression of the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells.

View Figures

View References

1.	Carmeliet P and Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature. 473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
2.	Holderfield MT and Hughes CC: Crosstalk between vascular endothelial growth factor, notch and transforming growth factor-beta in vascular morphogenesis. Circ Res. 102:637–652. 2008. View Article : Google Scholar : PubMed/NCBI
3.	Volz KS, Miljan E, Khoo A and Cooke JP: Development of pluripotent stem cells for vascular therapy. Vascul Pharmacol. 56:288–296. 2012. View Article : Google Scholar : PubMed/NCBI
4.	Xu Z, Fang S, Zuo Y, et al: Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis. Cancer Sci. 102:1789–1798. 2011. View Article : Google Scholar
5.	Sauer H, Gunther J, Hescheler J and Wartenberg M: Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am J Pathol. 156:151–158. 2000. View Article : Google Scholar : PubMed/NCBI
6.	Abid MR, Kachra Z, Spokes KC and Aird WC: NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 486:252–256. 2000. View Article : Google Scholar : PubMed/NCBI
7.	van Wetering S, van Buul JD, Quik S, et al: Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci. 115:1837–1846. 2002.PubMed/NCBI
8.	Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol. 552:335–344. 2003. View Article : Google Scholar : PubMed/NCBI
9.	Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS and Workman P: Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls and promises. Curr Opin Pharmacol. 8:393–412. 2008. View Article : Google Scholar : PubMed/NCBI
10.	McCubrey JA, Lahair MM and Franklin RA: Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 8:1775–1789. 2006. View Article : Google Scholar : PubMed/NCBI
11.	El-Najjar N, Chatila M, Moukadem H, et al: Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis. 15:183–195. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Risau W, Sariola H, Zerwes HG, et al: Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development. 102:471–478. 1988.PubMed/NCBI
13.	Wang R, Clark R and Bautch VL: Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development. 114:303–316. 1992.PubMed/NCBI
14.	Li X and Claesson-Welsh L: Embryonic stem cell models in vascular biology. J Thromb Haemost (Suppl). 1:53–56. 2009. View Article : Google Scholar
15.	Descamps B and Emanueli C: Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol. 56:267–279. 2012. View Article : Google Scholar : PubMed/NCBI
16.	Kawamura H, Li X, Goishi K, et al: Neuropilin-1 in regulation of VEGF-induced activation of p38^MAPK and endothelial cell organization. Blood. 112:3638–3649. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Han HJ, Heo JS and Lee YJ: Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes. Am J Physiol Cell Physiol. 290:C1067–C1075. 2006. View Article : Google Scholar : PubMed/NCBI
18.	Heo JS, Lee YJ and Han HJ: EGF stimulates proliferation of mouse embryonic stem cells: involvement of Ca²⁺ influx and p44/42 MAPKs. Am J Physiol Cell Physiol. 290:C123–C133. 2006.PubMed/NCBI
19.	Kim GD, Rhee GS, Chung HM, Chee KM and Kim GJ: Cytotoxicity of 5-fluorouracil: effect on endothelial differentiation via cell cycle inhibition in mouse embryonic stem cells. Toxicol In Vitro. 23:719–727. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Kim GD, Bae SY, Park HJ, Bae K and Lee SK: Honokiol inhibits vascular vessel formation of mouse embryonic stem cell-derived endothelial cells via the suppression of PECAM and MAPK/mTOR signaling pathway. Cell Physiol Biochem. 30:758–770. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Ho JW and Jie M: Pharmacological activity of cardiovascular agents from herbal medicine. Cardiovasc Hematol Agents Med Chem. 5:273–277. 2007. View Article : Google Scholar : PubMed/NCBI
22.	Amblard F, Govindarajan B, Lefkove B, et al: Synthesis, cytotoxicity and antiviral activities of new neolignans related to honokiol and magnolol. Bioorg Med Chem Lett. 17:4428–4431. 2007. View Article : Google Scholar : PubMed/NCBI
23	Park J, Lee J, Jung E, et al: In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol. 496:189–195. 2004. View Article : Google Scholar : PubMed/NCBI
24.	Tsai YC, Cheng PY, Kung CW, et al: Beneficial effects of magnolol in a rodent model of endotoxin shock. Eur J Pharmacol. 641:67–73. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Park JB, Lee MS, Cha EY, et al: Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway. Biol Pharm Bull. 35:1614–1620. 2012.PubMed/NCBI
26.	Chuang TC, Hsu SC, Cheng YT, et al: Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Cancer Lett. 311:11–19. 2011. View Article : Google Scholar : PubMed/NCBI
27.	Lin SY, Liu JD, Chang HC, Yeh SD, Lin CH and Lee WS: Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem. 84:532–544. 2002. View Article : Google Scholar : PubMed/NCBI
28.	Park EJ, Zhao YZ, Na M, et al: Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med. 69:33–37. 2003. View Article : Google Scholar : PubMed/NCBI
29.	Heuer J, Bremer S, Pohl I and Spielmann H: Development of an in vitro embryotoxicity test using murine embryonic stem cell cultures. Toxicol In Vitro. 7:551–556. 1993. View Article : Google Scholar : PubMed/NCBI
30.	Scholz G, Pohl I, Genschow E, Klemm M and Spielmann H: Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs. 165:203–211. 1999. View Article : Google Scholar : PubMed/NCBI
31.	Jakobsson L, Kreuger J, Holmborn K, et al: Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 10:625–634. 2006. View Article : Google Scholar : PubMed/NCBI
32.	Newman PJ: The biology of PECAM-1. J Clin Invest. 99:3–8. 1997. View Article : Google Scholar : PubMed/NCBI
33.	Sauer H, Rahimi G, Hescheler J and Wartenberg M: Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells. J Cell Biochem. 75:710–723. 1999. View Article : Google Scholar : PubMed/NCBI
34.	Sauer H and Wartenberg M: Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxid Redox Signal. 7:1423–1434. 2005. View Article : Google Scholar : PubMed/NCBI
35.	Karar J and Maity A: PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 4:512011. View Article : Google Scholar : PubMed/NCBI
36.	Olsson AK, Dimberg A, Kreuger J and Claesson-Welsh L: VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
37.	Sato Y: The vasohibin family: a novel family for angiogenesis regulation. J Biochem. 153:5–11. 2013. View Article : Google Scholar : PubMed/NCBI
38.	Frampton JE: Ranibizumab: in diabetic macular oedema. Drugs. 72:509–523. 2012. View Article : Google Scholar : PubMed/NCBI
39.	Hong SW, Jung KH, Lee HS, et al: SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway. Cancer Sci. 103:1929–1937. 2012. View Article : Google Scholar : PubMed/NCBI
40.	Hong SW, Jung KH, Lee HS, et al: Apoptotic and anti-angiogenic effects of Pulsatilla koreana extract on hepatocellular carcinoma. Int J Oncol. 40:452–460. 2012.PubMed/NCBI
41.	Nishikawa T, Tsuno NH, Okaji Y, et al: The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis. Angiogenesis. 13:227–238. 2010. View Article : Google Scholar : PubMed/NCBI
42.	Xu HL, Tang W, Du GH and Kokudo N: Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discov Ther. 5:202–210. 2011. View Article : Google Scholar : PubMed/NCBI
43.	Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
44.	Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
45.	McCubrey JA, Steelman LS, Chappell WH, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI
46.	Cho DH, Choi YJ, Jo SA, et al: Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition. Am J Physiol Cell Physiol. 291:C317–C326. 2006. View Article : Google Scholar
47.	Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell. 129:1261–1274. 2007. View Article : Google Scholar : PubMed/NCBI